XML 22 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED BALANCE SHEET - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Current assets    
Cash and cash equivalents ($333 and $491 related to VIEs) $ 2,829 $ 2,519
Marketable securities 130 69
Accounts receivable, net ($92 and $135 related to VIEs) 921 1,137
Contract assets ($130 and $171 related to VIEs) 1,138 991
Other current assets ($32 and $50 related to VIEs) 157 347
Total current assets 5,175 5,063
Noncurrent assets    
PP&E, net ($46 and $41 related to VIEs) 494 458
Investments 2,828 614
Deferred taxes 30 51
Deferred compensation trusts 221 241
Goodwill 199 206
Other assets ($17 and $127 related to VIEs) 196 340
Total noncurrent assets 3,968 1,910
Total assets 9,143 6,973
Current liabilities    
Accounts payable ($233 and $285 related to VIEs) 1,220 1,214
Contract liabilities ($278 and $276 related to VIEs) 684 639
Accrued salaries, wages and benefits ($18 and $25 related to VIEs) 640 653
Other accrued liabilities ($37 and $73 related to VIEs) 527 657
Total current liabilities 3,071 3,163
Long-term debt 1,104 1,158
Deferred taxes 468 70
Other noncurrent liabilities ($3 and $20 related to VIEs) 508 530
Contingencies and commitments
Shareholders' equity    
Common stock — authorized 375,000,000 shares ($0.01 par value); issued and outstanding — 169,228,759 and 170,405,512 shares in 2024 and 2023, respectively 2 2
APIC 1,174 1,228
AOCI (351) (269)
Retained earnings 3,124 979
Total shareholders' equity 3,949 1,940
NCI 43 112
Total equity 3,992 2,052
Total liabilities and equity $ 9,143 $ 6,973